Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,484.01
-18.3025-0.73%
Number of Gainers:51
Number of Losers:46
Number of Flat:- -
PE:- -
High:2,502.31
Open:2,502.31
Low:2,473.15
Close:2,502.31
Volume:1.52B
Turnover:314.03B
Market Cap:52.02T
Float Cap:48.68T

Loading ...

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

Asia Morning Call-Global Markets

Reuters
·
Oct 06

Intel's Stock Drops After Musk Hints at an Additional Partner for Big Chip Venture

Dow Jones
·
Oct 06

Bristol-Myers Squibb Co: Prelim Total Acquired Iprd and Licensing Income $1,536 Mln for Three Months Ended September 30, 2026

THOMSON REUTERS
·
Oct 06

Pinterest Shares Fall 2% After the Bell Following Announcement CFO to Step Down

THOMSON REUTERS
·
Oct 06

Granite Point Mortgage Trust Ups JPMorgan Repurchase Facility Cap to $727 Million

Reuters
·
Oct 06

Morgan Stanley Direct Lending Fund Updates Financial Calendar with Q3 Earnings Release, Conference Call

Reuters
·
Oct 06

Pinterest Names James Dibbo CFO Effective Oct. 26, 2026

Reuters
·
Oct 06

Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.35% on Oct 5: Key Drivers Unveiled

TradingKey
·
Oct 06

XP Inc Stock (XP) Closed Up by 30.93% on Oct 5: Key Drivers Unveiled

TradingKey
·
Oct 06

Pinterest Appoints James Dibbo Chief Financial Officer

THOMSON REUTERS
·
Oct 06

Pinterest - Julia Brau Donnelly to Remain as Advisor Through October 30, 2026

THOMSON REUTERS
·
Oct 06

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Reuters
·
Oct 06

Amazon Stores CEO Douglas Herrington Sells 1,000 Amazon Shares for $251,500 Under 10b5-1 Plan

Reuters
·
Oct 06

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS
·
Oct 06

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS
·
Oct 06

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS
·
Oct 06

Alamar Biosciences Names Former GRAIL CEO Bob Ragusa to Board

Reuters
·
Oct 06

Adeia - Agreement Renews Spectrum's License to Adeia's Media Ip for Pay-Tv, Broadband, Mobility

THOMSON REUTERS
·
Oct 06

Chemometec a/S - BlackRock Increases Voting Rights in Chemometec to 15.08% on Sept 29, 2026

THOMSON REUTERS
·
Oct 06